Covid-19: BioNTech/Pfizer Will Not Submit Vaccine for Emergency Use in Brazil
Pfizer pharmaceutical laboratory will not submit its immunizer developed in partnership with German BioNTech to fight the novel coronavirus for...
December 29, 2020Topic
Anvisa
Turkey Announces 91.25% CoronaVac Efficacy Against Covid-19
São Paulo Health Secretary says the CoronaVac vaccine, developed in partnership with the Butantan Institute, has not reached 90% efficacy,...
December 26, 2020
Brazil Health Regulator Sets Rules for COVID-19 Vaccine Emergency Use
Brazil’s health regulator Anvisa decided on Thursday to allow temporary emergency use authorizations for COVID-19 vaccines and set rules for...
December 10, 2020
São Paulo Governor Expects ANVISA Approval of Coronavac by January 15th
The Butantan Institute will forward the third phase of vaccine trials results to the agency on December 15th. This is...
December 10, 2020
Candida Auris: Brazil Issues Alert on Fatal Drug-Resistant ‘Super-Fungus’
The National Health Surveillance Agency (ANVISA) issued an alert on Monday, December 7th, about an ongoing investigation of a possible...
December 9, 2020
Vaccines Approved Abroad May Be Endorsed for Emergency Use in Brazil
Governors who met with Minister of Health Eduardo Pazuello on Tuesday, December 8th, stated that vaccines approved by international regulatory...
December 9, 2020
Brazil Health Regulator Analyzing Emergency Use of Covid-19 Vaccines – source
The news was first reported by the O Globo newspaper.
December 2, 2020
Brazil’s Court Postpones Decision on Who Pays for High-Cost Drugs
Brazil’s Supreme Court decided on Thursday that the Union, states and municipalities are 'jointly responsible' for the payment of the...
May 24, 2019